While generics may dominate due to cost advantages and meeting needs of a developing economy, there is a growing thrust ...

The European stock markets closed higher in Thursday trading as The Stoxx Europe rose 1.08%, Germany's DAX climbed 1.26%, the FTSE in London was up 0.51%, France's CAC advanced 1.32%, and the Swiss ...

And the risk of this happening increases with age (especially after 50 years), a compromised immune system (e.g. in HIV and ...

“Understanding Patient Data welcomes the publication of the Sudlow Review and its assertion that health data should be recognised as critical national infrastructure. The UK is uniquely positioned to ...

Global demand for menopause supplements is set to soar at 5.7% CAGR over the forecast period. North America is projected to ...

Nigeria's decision this week to block Shell's $2.4 billion sale of its onshore assets has sent a negative signal to investors ...

Harvey Jones thought he was getting a bargain when he snapped up these too much-loved FTSE 100 dividend growth stocks. Now they're getting on his nerves.

Syndax Pharmaceuticals and Royalty Pharma plc today announced that Syndax has entered into a $350 million synthetic royalty funding agreement with Royalty Pharma based on U.S. net sales ...

European markets were lower on Wednesday as investors assessed fresh corporate earnings and growth data, while looking ahead ...

Nigeria's decision to stop Shell (SHEL.L) from selling its $2.4 billion onshore assets to Renaissance Group has sent a ...

The FTSE 100 index slumped 99.42 points, 1.2%, at 8,025.77. The FTSE 250 closed down 295.73 points, 1.4%, at 20,427.80. The AIM All-Share fell 7.07 points, 1.0%, at 730.86.

Harvey Jones suffered some outsized losses on the FTSE 100 shares in his portfolio in October, but that only makes him look ...